IN SILICO ADMET SCREENING AND MOLECULAR DOCKING OF PHYTOCOMPOUNDS ASSOCIATED WITH Cannabis sativa L. WITH PREDICTED ANTITUBERCULAR POTENTIAL
DOI:
https://doi.org/10.66104/dq7xz711Keywords:
Cannabis sativa, tuberculosis, ADMET, molecular docking, InhA, alanine racemaseAbstract
Tuberculosis remains a major public health concern, further aggravated by the emergence of strains resistant to available treatments. In this context, computational tools can support the initial screening of molecules with potential interactions with essential targets of Mycobacterium tuberculosis. This study evaluated phytocompounds associated with Cannabis sativa L. through in silico ADMET prediction and molecular docking against the enzymes InhA and alanine racemase. Initially, 157 phytocompounds were assessed using 49 parameters, including eight physicochemical descriptors calculated with RDKit and 41 pharmacokinetic and toxicological endpoints predicted by Chemprop-RDKit models. Following a multicriteria analysis, 48 compounds were prioritized for subsequent stages. The PDB structures 6SQ9 and 6SCZ were used to represent InhA and alanine racemase, respectively, while the NAD⁺ and PLP cofactors were preserved as structural references for the catalytic sites. The docking protocol for InhA was validated by redocking, yielding an RMSD of 1.825 Å. Cannabisin E showed the most favorable predicted binding energy for InhA, at -10.3 kcal.mol-1, followed by Cannabisin C – Lignanamide, at -9.3 kcal.mol-1. For alanine racemase, Rutin – Flavonoids showed the most favorable result, at -9.3 kcal.mol-1, whereas Cannabisin C – Lignanamide reached -9.0 kcal.mol-1. The predicted complexes involved hydrogen bonds, van der Waals contacts, hydrophobic interactions, and aromatic interactions. Despite the favorable docking results, limitations related to permeability, bioavailability, polarity, molecular weight, and potential toxicological alerts were identified. The evaluated compounds therefore showed predicted in silico antituberculosis potential, although chemical optimization and experimental validation are still required.Downloads
References
AGUIAR, A. S. N.; VELOSO, C. M.; TEJOTA, Y. B. R.; MARTINS, J. L. R.; FAJEMIROYE, J. O.; BORGES, L. L.; CAMARGO, A. J.; DIAS, L. D.; NAPOLITANO, H. B. A comprehensive molecular analysis of cannabidiol: from solid state to antioxidant potential. Computational and Theoretical Chemistry, v. 1241, p. 114890, 2024. DOI: 10.1016/j.comptc.2024.114890. DOI: https://doi.org/10.1016/j.comptc.2024.114890
ANTHONY, K. G. et al. New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS ONE, v. 6, n. 5, e20374, 2011. DOI: 10.1371/journal.pone.0020374. DOI: https://doi.org/10.1371/journal.pone.0020374
BERMAN, H. M.; WESTBROOK, J.; FENG, Z.; GILLILAND, G.; BHAT, T. N.; WEISSIG, H.; SHINDYALOV, I. N.; BOURNE, P. E. The Protein Data Bank. Nucleic Acids Research, v. 28, n. 1, p. 235–242, 2000. DOI: 10.1093/nar/28.1.235. DOI: https://doi.org/10.1093/nar/28.1.235
BLASKOVICH, M. A. T. et al. The antimicrobial potential of cannabidiol. Scientific Reports, v. 11, n. 1, p. 1–18, 2021. DOI: 10.1038/s41598-021-81068-4.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual de recomendações para o controle da tuberculose no Brasil. 2. ed. Brasília, DF: Ministério da Saúde, 2022.
BRUNING, J. B.; MURILLO, A. C.; CHACÓN, O.; BARLETTA, R. G.; SACCHETTINI, J. C. Structure of the Mycobacterium tuberculosis D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrobial Agents and Chemotherapy, v. 55, n. 1, p. 291–301, 2011. DOI: 10.1128/AAC.00558-10. DOI: https://doi.org/10.1128/AAC.00558-10
CARABALÍ-ISAJAR, M. L.; RODRÍGUEZ-BEJARANO, O. H.; AMADO, T.; PATARROYO, M. A.; IZQUIERDO, M. A.; LUTZ, J. R.; OCAMPO, M. Clinical manifestations and immune response to tuberculosis. World Journal of Microbiology and Biotechnology, v. 39, n. 8, p. 206, 2023. DOI: 10.1007/s11274-023-03636-x. DOI: https://doi.org/10.1007/s11274-023-03636-x
DARTOIS, V.; DICK, T. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. Nature Reviews Drug Discovery, v. 23, p. 381–403, 2024. DOI: 10.1038/s41573-024-00897-5. DOI: https://doi.org/10.1038/s41573-024-00897-5
DHEDA, K. et al. The Lancet Commission on tuberculosis: tuberculosis elimination requires increased investments, accountability, and action. The Lancet, v. 403, n. 10444, p. 2146–2244, 2024. DOI: 10.1016/S0140-6736(24)00650-0. DOI: https://doi.org/10.1016/S0140-6736(24)00650-0
EBERHARDT, J.; SANTOS-MARTINS, D.; TILLACK, A. F.; FORLI, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. Journal of Chemical Information and Modeling, v. 61, n. 8, p. 3891–3898, 2021. DOI: 10.1021/acs.jcim.1c00203. DOI: https://doi.org/10.1021/acs.jcim.1c00203
HEVENER, K. E.; ZHAO, W.; BALL, D. M.; BABAOGLOU, K.; QI, J.; WHITE, S. W.; LEE, R. E. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. Journal of Chemical Information and Modeling, v. 49, n. 2, p. 444–460, 2009. DOI: 10.1021/ci800293n. DOI: https://doi.org/10.1021/ci800293n
HOHENBERG, P.; KOHN, W. Inhomogeneous electron gas. Physical Review B, v. 136, n. 3B, p. B864–B871, 1964. DOI: 10.1103/PhysRev.136.B864. DOI: https://doi.org/10.1103/PhysRev.136.B864
JUNG, W.; LEE, J.; KIM, H.; LEE, K. Absorption, distribution, metabolism, excretion, and toxicity prediction in drug discovery. Molecules, v. 29, n. 6, p. 1380, 2024. DOI: 10.3390/molecules29061380. DOI: https://doi.org/10.3390/molecules29061380
LAN, Y. et al. Integrating genomic and spatial analyses to describe tuberculosis transmission: a scoping review. The Lancet Microbe, v. 6, n. 8, p. 101094, 2025. DOI: 10.1016/j.lanmic.2025.101094. DOI: https://doi.org/10.1016/j.lanmic.2025.101094
LEE, C.; YANG, W.; PARR, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B: Condensed Matter, v. 37, n. 2, p. 785–789, 1988. DOI: 10.1103/PhysRevB.37.785. DOI: https://doi.org/10.1103/PhysRevB.37.785
LEE, S.; LEE, Y.; KIM, Y.; KIM, H.; RHYU, H.; YOON, K.; LEE, C.-D.; LEE, S. Beneficial effects of cannabidiol from Cannabis. Applied Biological Chemistry, v. 67, n. 32, 2024. DOI: 10.1186/s13765-024-00867-w. DOI: https://doi.org/10.1186/s13765-024-00867-w
LIPINSKI, C. A.; LOMBARDO, F.; DOMINY, B. W.; FEENEY, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, v. 46, n. 1–3, p. 3–26, 2001. DOI: 10.1016/S0169-409X(00)00129-0. DOI: https://doi.org/10.1016/S0169-409X(96)00423-1
MARRAKCHI, H.; LANEELLE, M. A.; QUÉMARD, A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology, v. 146, n. 2, p. 289–296, 2000. DOI: 10.1099/00221287-146-2-289. DOI: https://doi.org/10.1099/00221287-146-2-289
MORALES, P. et al. Phytocannabinoids and their therapeutic potential in drug discovery. Pharmacological Research, v. 170, p. 105548, 2021. DOI: 10.1016/j.phrs.2021.105548. DOI: https://doi.org/10.1016/j.phrs.2021.105548
OMOTAYO, O. P.; LEMMER, Y.; MASON, S. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. Journal of Cannabis Research, v. 6, n. 14, 2024. DOI: 10.1186/s42238-024-00222-2. DOI: https://doi.org/10.1186/s42238-024-00222-2
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
O’SULLIVAN, S. E. et al. The therapeutic potential of purified cannabidiol. Journal of Cannabis Research, v. 5, n. 1, 2023. DOI: 10.1186/s42238-023-00186-9. DOI: https://doi.org/10.1186/s42238-023-00186-9
PERES, F. F.; LEITE, J. P.; DEL BEL, E. A.; GUIMARÃES, F. S. Cannabidiol as a promising compound for neurological disorders: mechanisms and therapeutic perspectives. Frontiers in Pharmacology, v. 15, 2024. DOI: 10.3389/fphar.2024.1403147. DOI: https://doi.org/10.3389/fphar.2024.1403147
PETTERSEN, E. F.; GODDARD, T. D.; HUANG, C. C.; COUCH, G. S.; GREENBLATT, D. M.; MENG, E. C.; FERRIN, T. E. UCSF Chimera: a visualization system for exploratory research and analysis. Journal of Computational Chemistry, v. 25, n. 13, p. 1605–1612, 2004. DOI: 10.1002/jcc.20084. DOI: https://doi.org/10.1002/jcc.20084
PINZI, L.; RASTELLI, G. Molecular docking: shifting paradigms in drug discovery. International Journal of Molecular Sciences, v. 20, n. 18, p. 4331, 2019. DOI: 10.3390/ijms20184331. DOI: https://doi.org/10.3390/ijms20184331
PO, H. N.; SENOZAN, N. M. The Henderson-Hasselbalch equation: its history and limitations. Journal of Chemical Education, v. 78, n. 11, p. 1499–1503, 2001. DOI: 10.1021/ed078p1499. DOI: https://doi.org/10.1021/ed078p1499
POTLITZ, F.; LINK, A.; SCHULIG, L. Advances in the discovery of new chemotypes through ultra-large library docking. Expert Opinion on Drug Discovery, v. 18, n. 3, p. 303–313, 2023. DOI: 10.1080/17460441.2023.2171984. DOI: https://doi.org/10.1080/17460441.2023.2171984
RAHLWES, K. C.; DIAS, B. R. S.; CAMPOS, P. C.; ALVAREZ-ARGUEDAS, S.; SHILOH, M. U. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence, v. 14, n. 1, p. 2150449, 2023. DOI: 10.1080/21505594.2022.2150449. DOI: https://doi.org/10.1080/21505594.2022.2150449
SCHRÖDINGER, LLC. The PyMOL Molecular Graphics System, Version 3.1. New York: Schrödinger, LLC, 2025.
SENELLE, G. et al. Towards a better understanding of the long-lasting evolutionary history of Mycobacterium tuberculosis. Tuberculosis, v. 143, p. 102374, 2023. DOI: 10.1016/j.tube.2023.102374. DOI: https://doi.org/10.1016/j.tube.2023.102374
SWANSON, K.; WALTHER, P.; LEITZ, J.; MUKHERJEE, S.; WU, J. C.; SHIVNARAINE, R. V.; ZOU, J. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics, v. 40, n. 7, btae416, 2024. DOI: 10.1093/bioinformatics/btae416. DOI: https://doi.org/10.1093/bioinformatics/btae416
WARNER, D. F.; BARCZAK, A. K.; GUTIERREZ, M. G.; MIZRAHI, V. et al. Mycobacterium tuberculosis biology, pathogenicity and interaction with the host. Nature Reviews Microbiology, v. 23, p. 788–804, 2025. DOI: 10.1038/s41579-025-01201-x. DOI: https://doi.org/10.1038/s41579-025-01201-x
WEININGER, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Sciences, v. 28, n. 1, p. 31–36, 1988. DOI: 10.1021/ci00057a005. DOI: https://doi.org/10.1021/ci00057a005
WRIGHT, N. J. D. A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol. AIMS Neuroscience, v. 11, n. 2, p. 144–165, 2024. DOI: 10.3934/Neuroscience.2024009. DOI: https://doi.org/10.3934/Neuroscience.2024009
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Gabrielle Maia Pismel , Andressa de Paula Amaral Sanches, Wellington Lopes de Sousa Filho, Alessandro Quaresma Durães de Sousa, Lucas Piani Corrêa, Agnaldo da Silva Carneiro

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
